The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis

115Citations
Citations of this article
280Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SAR2-COV-2) and was first identified in Wuhan, China, in December of 2019, but quickly spread to the rest of the world, causing a pandemic. While some studies have found no link between smoking status and severe COVID-19, others demonstrated a significant one. The present study aimed to determine the relationship between smoking and clinical COVID-19 severity via a systematic meta-analysis approach. Methods. We searched the Google Scholar, PubMed, Scopus, Web of Science, and Embase databases to identify clinical studies suitable for inclusion in this meta-analysis. Studies reporting smoking status and comparing nonsevere and severe patients were included. Nonsevere cases were described as mild, common type, nonintensive care unit (ICU) treatment, survivors, and severe cases as critical, need for ICU, refractory, and nonsurvivors. Results. A total of 16 articles detailing 11322 COVID-19 patients were included. Our meta-analysis revealed a relationship between a history of smoking and severe COVID-19 cases (OR=2.17; 95% CI: 1.37-3.46; P

Cite

CITATION STYLE

APA

Gülsen, A., Yigitbas, B. A., Uslu, B., Drömann, D., & Kilinc, O. (2020). The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulmonary Medicine, 2020. https://doi.org/10.1155/2020/7590207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free